CClinicalTrials.gg
Status unknownNCT03703739Updated Oct 12, 2018

Iron Absorption From Iron Fortified Extruded Rice Co-fortified With Various Solubilizing Agents

An interventional study of Reference meal 1 and Reference 2 in Iron-deficiency, sponsored by Swiss Federal Institute of Technology. Status unknown at 1 site in Switzerland. Open to female participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-10-12.

Sponsored by Swiss Federal Institute of Technology · Not applicable, Interventional, and Prevention

The sponsor has not verified this record recently (last verified Oct 2018), so the status shown — last known as Active, not recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
22
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
Female
01

Study summary

Food fortification is regarded as a safe and cost-effective approach to counteract and prevent iron deficiency. Rice is a staple food for millions of people living in regions where iron-deficiency anaemia is a significant public health problem. Therefore, rice may be a promising fortification vehicle. Ferric pyrophosphate (FePP) is an acceptable iron compound for rice fortification, due to its white colour and low reactivity with the rice matrix. However, iron from FePP generally has a low bioavailability. To increase the low iron bioavailability of FePP in fortified rice, ligands acting as solubilizing agents have been suggested, such as citric acid/trisodium citrate (CA/TSC), ethylenediaminetetraacetic acid (EDTA) and sodium pyrophosphate (NaPP).

It is however unclear to which extent CA/TSC would enhance iron bioavailability in presence of phytic acid, a common inhibitor of iron absorption found in whole grains and legumes. Zinc oxide reduces iron bioavailability from FePP with and without CA/TSC, in contrast to Zinc sulphate. It is however unclear if this decrease would be also expected in presence of EDTA as solubilizing agent. Further, NaPP has been suggested as a solubilizing agent, enhancing the bioavailability from FePP in bouillon cubes. This study aim to test its effect in rice. Meals containing a high (bean sauce) and low (mixed vegetable) phytic acid level sauce will be used to simulated varying dietary backgrounds, allowing to answer the question which solubilizing agent is viable in enhancing iron bioavailability.

02

Conditions studied

  • Iron-deficiency

Keywords

  • Iron deficiency
  • iron fortified rice
  • extruded rice
03

In context

Anemia, Iron-Deficiency

644 studies on the registry are indexed under Anemia, Iron-Deficiency; 105 are open to participants now.

This study's enrollment of 22 is below the median of 100 across 503 interventional studies indexed under Anemia, Iron-Deficiency.

Browse Anemia, Iron-Deficiency studies →

Lead sponsor

Swiss Federal Institute of Technology is the lead sponsor of 152 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Female, 18 to 40 years old
  • Normal body Mass Index (18.5 - 25 kg/m2)
  • Body weight ≤ 65 kg
  • Signed informed consent

Exclusion criteria

Exclusion Criteria:

  • Pregnancy (assessed by self-declaration)
  • Lactating up to 6 weeks before study initiation
  • Anaemia (Hb \< 12.0 g/dL)
  • Elevate CRP (>5.0 mg/L)
  • Any metabolic, gastrointestinal kidney or chronic disease such as diabetes, hepatitis, hypertension, cancer or cardiovascular diseases (according to the participants own statement)
  • Continuous/long-term use of medication during the whole study (except for contraceptives)
  • Consumption of mineral and vitamin supplements within 2 weeks prior to 1st meal administration
  • Blood transfusion, blood donation or significant blood loss (accident, surgery) over the past 4 months
  • Earlier participation in a study using Fe stable isotopes or participation in any clinical study within the last 30 days
  • Participant who cannot be expected to comply with study protocol (e.g. not available on certain study appointments)
  • Smokers (> 1 cigarette per week)
  • Difficulties with blood sampling
  • Male gender
  • Do not understand English
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
22 participants (actual)

Study arms

  • Active comparator
    Reference meal 1

    50 g of Commercial Rice (Jasmin Rice) (dry weight) was cooked and 4 mg iron from Ferrous sulfate was added Prior to give to participants. Rice meal consumed with mixed vegetable Sauce.

    Dietary Supplement: Reference meal 1

  • Active comparator
    Reference 2

    50 g of Commercial Rice (Jasmin Rice) (dry weight) was cooked and 4 mg iron from Ferrous sulfate was added Prior to give to participants. Rice meal consumed with bean sauce.

    Dietary Supplement: Reference 2

  • Experimental
    Test meal A

    Commercial Rice (Jasmin Rice) was mixed with iron fortified extuded rice cofortified with zinc oxide and ethylenediaminetetraacetic acid (mixing ratio 100:1), Rice meal consumed with mixed vegetable Sauce.

    Dietary Supplement: Test meal A

  • Experimental
    Test meal B

    Commercial Rice (Jasmin Rice) was mixed with iron fortified extuded rice co-fortified with zinc sulfate and ethylenediaminetetraacetic acid (mixing ratio 100:1), Rice meal consumed with mixed vegetable Sauce.

    Dietary Supplement: Test meal B

  • Experimental
    Test meal C

    Commercial Rice (Jasmin Rice) was mixed with iron fortified extuded rice co-fortified with zinc sulfate, citric acid and trisodium citrate (mixing ratio 100:1), Rice meal consumed with mixed vegetable Sauce.

    Dietary Supplement: Test meal C

  • Experimental
    Test meal D

    Commercial Rice (Jasmin Rice) was mixed with iron fortified extuded rice co-fortified with zinc sulfafe and sodium pyrophosphate (mixing ratio 100:1), Rice meal consumed with mixed vegetable Sauce.

    Dietary Supplement: Test meal D

  • Experimental
    Test meal E

    Commercial Rice (Jasmin Rice) was mixed with iron fortified extuded rice co-fortified with zinc sulfate, citric acid and trisodium citrate (mixing ratio 100:1), Rice meal consumed with bean Sauce.

    Dietary Supplement: Test meal E

Interventions

  • Dietary supplementReference meal 1

    1 ml Ferrous sulfate solution (4mgFe/ml) was added in cooked comercial Rice Prior to served to participant. The meal served with 30 g mixed vegetable Sauce and 300 ml nanopure water

  • Dietary supplementReference 2

    1 ml Ferrous sulphate solution (4mgFe/ml) was added in cooked comercial Rice Prior to served to participant. The meal served with 30 g bean Sauce and 300 ml nanopure water

  • Dietary supplementTest meal A

    Fortified extruded Rice was mixed with Commercial Rice (mixing Ratio: 1:100) The meal served with 30 g vegetable Sauce and 300 ml nanopure water. \*\* composition of extruded Rice: Ferric pyrophosphate, zinc oxide and ethylenediaminetetraacetic acid

  • Dietary supplementTest meal B

    Fortified extruded Rice was mixed with Commercial Rice (mixing Ratio: 1:100) The meal served with 30 g vegetable Sauce and 300 ml nanopure water. \*\* composition of extruded Rice: Ferric pyrophosphate, zinc sulfate and ethylenediaminetetraacetic acid

  • Dietary supplementTest meal C

    Fortified extruded Rice was mixed with Commercial Rice (mixing Ratio: 1:100) The meal served with 30 g vegetable Sauce and 300 ml nanopure water. \*\* composition of extruded Rice: Ferric pyrophosphate, zinc sulfate, citric acid and trisodium Citrate.

  • Dietary supplementTest meal D

    Fortified extruded Rice was mixed with Commercial Rice (mixing Ratio: 1:100) The meal served with 30 g vegetable Sauce and 300 ml nanopure water. \*\* composition of extruded Rice: Ferric pyrophosphate, zinc sulfate and sodium pyrophosphate.

  • Dietary supplementTest meal E

    Fortified extruded Rice was mixed with Commercial Rice (mixing Ratio: 1:100) The meal served with 30 g bean Sauce and 300 ml nanopure water. \*\* composition of extruded Rice: Ferric pyrophosphate, zinc sulfate, citric acid and trisodium Citrate.

06

What researchers measure

Primary outcomes

  1. Change from baseline in the isotopic ratio of iron in blood at week 2

    The change in the isotopic ratio of iron will be measured after the administration of test meal including iron isotopes.

    Time frame: baseline, 2 weeks

  2. Change from week 2 in the isotopic ratio of iron in blood at week 4

    The change in the isotopic ratio of iron will be measured after the administration of test meal including iron isotopes.

    Time frame: 2 weeks, 4 weeks

  3. Change from week 4 in the isotopic ratio of iron in blood at week 6

    The change in the isotopic ratio of iron will be measured after the administration of test meal including iron isotopes.

    Time frame: 4 weeks, 6 weeks

  4. Change from week 6 in the isotopic ratio of iron in blood at week 8

    The change in the isotopic ratio of iron will be measured after the administration of test meal including iron isotopes.

    Time frame: 6 weeks, 8 weeks

  5. Change from week 8 in the isotopic ratio of iron in blood at week 10

    The change in the isotopic ratio of iron will be measured after the administration of test meal including iron isotopes.

    Time frame: 8 weeks, 10 weeks

Secondary outcomes

  1. Haemoglobin

    Haemoglobin of each timepoint

    Time frame: 2, 4,6,8 and 10 weeks

  2. Plasma Ferritin

    Plasma Ferritin of each timepoint

    Time frame: 2, 4, 6, 8 and 10 weeks

  3. Inflammation Marker

    Plasma Ferririn of each timepoint

    Time frame: 2, 4, 6, 8 and 10 weeks

07

Study locations

1 site
  • Human Nutrition Laboratory, ETH Zurich
    Zürich, 8092, Switzerland
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 12, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03703739
Lead sponsor
Swiss Federal Institute of Technology
Responsible party
Sponsor
First posted
Oct 12, 2018
Start date
Oct 2, 2018
Primary completion
Dec 2018 (estimated)
Completion
Dec 2018 (estimated)
Last update
Oct 12, 2018

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Oct 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion